secwatch.observer — SEC 8-K summary
======================================

Issuer:     SURGALIGN HOLDINGS, INC. (—)
CIK:        0001760173
Form:       8-K
Filed at:   2023-03-06T23:59:59+00:00
Accession:  0001193125-23-060816
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgalign sells Coflex/Cofix product lines to Xtant Medical for $17M cash
-------------------------------------------------------------------------

- Sold 100% of Surgalign SPV equity to Xtant Medical for $17M cash.
- Transaction closed Feb 28, 2023; includes Coflex/Cofix product lines and worldwide IP.
- Pro forma shows removal of ~$10.9M revenue (9M 2022) and ~$17.8M (FY2021).
- Estimated gain on disposal of $13.5M recorded in pro forma; actual gain in Q1 2023.
- Transition services agreement signed for post-closing support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1760173/000119312523060816/0001193125-23-060816-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1760173/000119312523060816/d439544d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-060816

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer